Bausch Health Companies Inc. Indenture Agreements

100 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sixteenth Supplemental Indenture to 8.500% Senior Notes Due 2027 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 5.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 7.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fifteenth Supplemental Indenture to 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Sixteenth Supplemental Indenture to 9.250% Senior Notes Due 2026 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Indenture for $998,937,000 9.000% Senior Secured Notes Due 2028 between 1375209 B.C. Ltd. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Indenture for Bausch Health Companies Inc. $351,533,000 14.000% Second Lien Secured Notes Due 2030
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for $1,774,067,000 11.00% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for $1,600,000,000 4.875% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2021
Indenture for $1,000,000,000 5.000% Senior Notes Due 2029 and $1,000,000,000 5.250% Senior Notes Due 2031 by Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Indenture for $1,500,000,000 6.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Indenture for $1,250,000,000 5.000% Senior Notes Due 2028 and $1,250,000,000 5.250% Senior Notes Due 2030 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Indenture for $750,000,000 7.000% Senior Notes Due 2028 and $750,000,000 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Indenture Agreement for $750,000,000 8.500% Senior Notes Due 2027 between Valeant Pharmaceuticals International and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2018
Indenture for $1,500,000,000 9.000% Senior Notes Due 2025 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2017
Supplemental Indenture to Assume and Guarantee Senior Notes among Valeant Pharmaceuticals, Guarantors, and Trustee (March 27, 2015)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for Senior Notes Due 2020, 2023, and 2025 between VRX Escrow Corp. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for 5.50% Senior Notes Due 2023 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for 5.625% Senior Notes Due 2021 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 6.875% Senior Notes Due 2018 – Valeant Pharmaceuticals, Sanitas, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 6.75% Senior Notes Due 2021 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to July 2013 Indenture—Valeant Pharmaceuticals, Sanitas, and BNY Mellon Trust
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, Labenne Participações Ltda., Probiótica Laboratórios Ltda., and The Bank of...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals International, Labenne Participações Ltda., Probiótica Laboratórios Ltda., and The Bank of New...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals, Labenne Participações, Probiótica Laboratórios, and The Bank of New York Mellon...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, VLLC, VP, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 2011 Indenture among Valeant Entities and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to 6.375% Senior Notes Due 2020—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Entities and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, Jelfa, VEBV, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013